In this Cancer Matters podcast, Dr Bill Nelson and Dr Elizabeth Jaffee discuss two significant breakthroughs in pancreatic cancer. The first is daraxonrasib, a drug… Read More »Cancer Matters with Dr. Bill Nelson – Pancreatic Cancer Breakthroughs
In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Elizabeth Jaffee about her research in cancer vaccines, immunotherapy, and the importance of federal… Read More »Cancer Matters with Dr. Bill Nelson – Cancer Vaccine Research
In this podcast looking back at the first 50 years of the Cancer Center at Johns Hopkins, Dr Bill Nelson and Dr Elizabeth Jaffee highlight… Read More »50th Anniversary of the Kimmel Cancer Center – Female Pioneers
Dr Bill Nelson and Dr Elizabeth Jaffee discuss the creation of Break Through Cancer, a new collaborative partnership between The Johns Hopkins Kimmel Cancer Center,… Read More »Cancer Matters with Dr. Bill Nelson – Break Through Cancer
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or… Read More »Breast Cancer Cells Can Reprogram Immune Cells To Assist In Metastasis
In our next podcast, Dr Bill Nelson speaks with Kimmel Cancer Center Deputy Director, Dr Elizabeth Jaffee, to review her year as President of the… Read More »Cancer Matters with Dr. Bill Nelson – AACR President Dr. Elizabeth Jaffee
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important… Read More »Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Dr Bill Nelson, the Director of the Kimmel Cancer Center at Johns Hopkins, begins a new podcast series focused on cancer treatment and research. In… Read More »Cancer Matters with Dr. Bill Nelson – New AACR President Dr. Elizabeth Jaffee